Taysha Gene Therapies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Taysha Gene Therapies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • Taysha Gene Therapies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $8.68M, a 11.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $8.68M -$1.17M -11.9% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $8.97M -$1.38M -13.3% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $9.26M -$1.39M -13% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $9.58M -$1.36M -12.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $9.85M Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $10.3M Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $10.6M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $10.9M Dec 31, 2022 10-K 2024-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.